METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin

ABSTRACT: This study aims to determine the efficacy, safety, and tolerability of the sequential addition of immune-modulating therapy to standard-of-care therapy of microsatellite-stable (MSS)/mismatch repair-proficient (pMMR) metastatic colorectal cancer (mCRC).

DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic,Cancer

PROVIDER: 2262423 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR